Related Experiment Video
Updated: Jun 15, 2025
08:50
Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
13.2K
[Neuromuscular Blockade in Paediatric Patients].
Summary
Muscle relaxants are vital in anesthesia, but infants and young children need specific, adapted administration protocols. This article details these crucial considerations for pediatric anesthesia.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
- Critical Care Medicine
Background:
- Muscle relaxants have been a cornerstone of anesthesia for decades.
- Their use is integral to modern anesthetic practice.
- Specialized patient populations necessitate tailored approaches to drug administration.
Purpose of the Study:
- To elucidate the specific considerations for administering muscle relaxants in pediatric patients.
- To highlight adaptations required for infants and very young children undergoing anesthesia.
- To provide guidance on the safe and effective use of neuromuscular blocking agents in pediatric populations.
Main Methods:
- Review of existing literature on muscle relaxant use in pediatric anesthesia.
- Analysis of pharmacokinetic and pharmacodynamic differences in infants and children.
- Discussion of clinical challenges and best practices for neuromuscular blockade in pediatric patients.
Main Results:
- Pediatric patients exhibit distinct responses to muscle relaxants compared to adults.
- Dosage, onset, duration, and reversal of neuromuscular blockade require careful adjustment in neonates and infants.
- Specific agents and monitoring techniques are recommended for optimizing safety and efficacy.
Conclusions:
- Adapted administration of muscle relaxants is essential for safe and effective anesthesia in infants and young children.
- Understanding pediatric-specific physiology is key to managing neuromuscular blockade.
- Further research into optimized pediatric neuromuscular blockade strategies is warranted.
Related Concept Videos
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
401
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
01:29Neuromuscular Junction And Blockade
3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
437
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
437
01:31Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
01:19Depolarizing Blockers: Pharmocokinetics
315
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
315